During the past decade, Instituto Dante Pazzanese De Cardiologia conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 6 clinical trials were completed, i.e. on average, 16.2% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 4 clinical trials were completed. i.e. 22.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instituto Dante Pazzanese De Cardiologia" #1 sponsor was "Instituto Dante Pazzanese de Cardiologia" with 8 trials, followed by "Scitech Produtos Medicos Ltda" with 5 trials sponsored, "Elixir Medical Corporation" with 4 trials sponsored, "Hospital Israelita Albert Einstein" with 4 trials sponsored and "Cordis Corporation" with 4 trials sponsored. Other sponsors include 44 different institutions and companies that sponsored additional 41 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto Dante Pazzanese De Cardiologia" #1 collaborator was "Instituto Dante Pazzanese de Cardiologia" with 6 trials as a collaborator, "Ministry of Health, Brazil" with 5 trials as a collaborator, "Fundação de Amparo à Pesquisa do Estado de São Paulo" with 4 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 2 trials as a collaborator and "Medtronic" with 2 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Instituto Dante Pazzanese De Cardiologia" are "Coronary Artery Disease" (25 trials), "Cardiovascular Diseases" (5 trials), "Coronary Disease" (4 trials), "Acute Coronary Syndrome" (3 trials) and "Atrial Fibrillation" (3 trials). Many other conditions were trialed in "Instituto Dante Pazzanese De Cardiologia" in a lesser frequency.

Most popular intervention types in "Instituto Dante Pazzanese De Cardiologia" are "Device" (32 trials), "Drug" (21 trials), "Other" (4 trials), "Procedure" (4 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Intensive Control of Systolic Blood Pressure (SBP)" (2 trials), "Rosuvastatin" (2 trials), "Standard control of Systolic Blood Pressure (SBP)" (2 trials) and "A conventional device" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Dante Pazzanese De Cardiologia" are 73 trials for "All" genders.

Currently, there are NaN active trials in "Instituto Dante Pazzanese De Cardiologia". undefined are not yet recruiting, 12 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 42 completed trials in Instituto Dante Pazzanese De Cardiologia, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Dante Pazzanese De Cardiologia, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 14 trials, and there were also 34 trials that are defined as “Not Applicable".

Instituto Dante Pazzanese De Cardiologia has several departments that took part in Clinical trials: "Instituto de Cardiologia Dante Pazzanese Unidadae II Recepcao de Angioplastia" - 3 trials